{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:47:00Z","timestamp":1789991220611,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,16]],"date-time":"2020-01-16T00:00:00Z","timestamp":1579132800000},"content-version":"vor","delay-in-days":3486,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY012509"],"award-info":[{"award-number":["EY012509"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.2353\/ajpath.2010.090604","type":"journal-article","created":{"date-parts":[[2010,5,20]],"date-time":"2010-05-20T22:45:00Z","timestamp":1274395500000},"page":"132-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["N-Acetylcysteine Suppresses Retinal Detachment in an Experimental Model of Proliferative Vitreoretinopathy"],"prefix":"10.1016","volume":"177","author":[{"given":"Hetian","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Samad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maberley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrius","family":"Kazlauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2353\/ajpath.2010.090604_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archopht.1997.01100150239014","article-title":"Pathogenic mechanisms in proliferative vitreoretinopathy","volume":"115","author":"Campochiaro","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0161-6420(87)33443-8","article-title":"Proliferative vitreoretinopathy: the mechanism of development of vitreoretinal traction","volume":"94","author":"Glaser","year":"1987","journal-title":"Ophthalmology"},{"key":"10.2353\/ajpath.2010.090604_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/bjo.82.2.106","article-title":"Growth factors in proliferative vitreoretinopathy","volume":"82","author":"Charteris","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0002-9394(75)90390-6","article-title":"Glial cell proliferation in retinal detachment (massive periretinal proliferation)","volume":"80","author":"Laqua","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9394(14)73518-4","article-title":"Traction retinal detachment. XLIX Edward Jackson Memorial Lecture","volume":"115","author":"Ryan","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0002-9394(82)90239-2","article-title":"Fluorouracil for the treatment of massive periretinal proliferation","volume":"94","author":"Blumenkranz","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9394(87)90286-8","article-title":"Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy","volume":"104","author":"Wiedemann","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib8","first-page":"719","article-title":"Daunomycin in the treatment of experimental proliferative vitreoretinopathy: effective doses in vitro and in vivo","volume":"26","author":"Wiedemann","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/jop.2007.0044","article-title":"Cyclin-dependent kinase inhibitor roscovitine induces cell cycle arrest and apoptosis in rabbit retinal pigment epithelial cells","volume":"24","author":"Wu","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.2353\/ajpath.2010.090604_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/02713680802226582","article-title":"Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186","volume":"33","author":"Falkenstein","year":"2008","journal-title":"Curr Eye Res"},{"key":"10.2353\/ajpath.2010.090604_bib11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0896-1549(01)00008-6","article-title":"Mechanisms in proliferative vitreoretinopathy","volume":"15","author":"Kim","year":"2002","journal-title":"Ophthalmol Clin North Am"},{"key":"10.2353\/ajpath.2010.090604_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000268022","article-title":"Ocular gene therapy: experimental studies and clinical possibilities","volume":"29","author":"Murata","year":"1997","journal-title":"Ophthalmic Res"},{"key":"10.2353\/ajpath.2010.090604_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajo.2008.05.002","article-title":"Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy","volume":"146","author":"Chang","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/eye.2009.13","article-title":"New paradigms in the treatment of wet AMD: the impact of anti-VEGF therapy","volume":"23 Suppl 1","author":"Menon","year":"2009","journal-title":"Eye"},{"key":"10.2353\/ajpath.2010.090604_bib15","first-page":"S65","article-title":"Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST)","volume":"83 Suppl 1","author":"Hochhaus","year":"2004","journal-title":"Ann Hematol"},{"key":"10.2353\/ajpath.2010.090604_bib16","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1167\/iovs.06-0965","article-title":"A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy","volume":"48","author":"Lei","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.exer.2008.10.020","article-title":"PDGF receptors are activated in human epiretinal membranes","volume":"88","author":"Cui","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.2353\/ajpath.2010.090604_bib18","first-page":"2683","article-title":"Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy","volume":"40","author":"Andrews","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib19","first-page":"3107","article-title":"Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor","volume":"41","author":"Ikuno","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib20","first-page":"2406","article-title":"An in vivo gene therapy approach for experimental proliferative vitreoretinopathy using the truncated platelet-derived growth factor alpha receptor","volume":"43","author":"Ikuno","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib21","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1074\/jbc.M808426200","article-title":"Growth factors outside of the PDGF family employ ROS\/SFKs to activate PDGF receptor alpha and thereby promote proliferation and survival of cells","volume":"284","author":"Lei","year":"2009","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090604_bib22","doi-asserted-by":"crossref","first-page":"28335","DOI":"10.1074\/jbc.274.40.28335","article-title":"Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis","volume":"274","author":"Rosenkranz","year":"1999","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090604_bib23","first-page":"2388","article-title":"Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy","volume":"36","author":"Nakagawa","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0008-4182(02)80112-0","article-title":"Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells","volume":"37","author":"Wong","year":"2002","journal-title":"Can J Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib25","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1074\/jbc.273.10.5908","article-title":"A role for Src in signal relay by the platelet-derived growth factor alpha receptor","volume":"273","author":"Gelderloos","year":"1998","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090604_bib26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.eye.6702011","article-title":"Vitreous leptin levels in retinal disease","volume":"20","author":"Maberley","year":"2006","journal-title":"Eye"},{"key":"10.2353\/ajpath.2010.090604_bib27","doi-asserted-by":"crossref","first-page":"15926","DOI":"10.1074\/jbc.M909616199","article-title":"Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor: key role for the p66 adaptor protein Shc","volume":"275","author":"Heeneman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.2353\/ajpath.2010.090604_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.270.5234.296","article-title":"Requirement for generation of H2O2 for platelet-derived growth factor signal transduction","volume":"270","author":"Sundaresan","year":"1995","journal-title":"Science"},{"key":"10.2353\/ajpath.2010.090604_bib29","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1167\/iovs.07-1302","article-title":"Connective tissue growth factor as a mediator of intraocular fibrosis","volume":"49","author":"He","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.2353\/ajpath.2010.090604_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10792-007-9053-x","article-title":"Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders","volume":"27","author":"Abu El-Asrar","year":"2007","journal-title":"Int Ophthalmol"},{"key":"10.2353\/ajpath.2010.090604_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0002-9394(14)77369-6","article-title":"A comparison of different cellular inocula in an experimental model of massive periretinal proliferation","volume":"93","author":"Fastenberg","year":"1982","journal-title":"Am J Ophthalmol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944010600703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:58:01Z","timestamp":1757599081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944010600703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0002944010600703"],"URL":"https:\/\/doi.org\/10.2353\/ajpath.2010.090604","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-Acetylcysteine Suppresses Retinal Detachment in an Experimental Model of Proliferative Vitreoretinopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.2353\/ajpath.2010.090604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}